Literature DB >> 32330276

Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.

Stephan D Fihn1,2,3, Eli Perencevich4,5,6, Steven M Bradley6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32330276     DOI： 10.1001/jamanetworkopen.2020.9035

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  20 in total

Review 1.  Dentistry during and after COVID-19 Pandemic: Pediatric Considerations.

Authors:  Anuraj Singh Kochhar; Ritasha Bhasin; Gulsheen Kaur Kochhar; Himanshu Dadlani; Balvinder Thakkar; Gurkeerat Singh
Journal:  Int J Clin Pediatr Dent       Date:  2020 Jul-Aug

2.  Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19.

Authors:  Marine Ambar Akkaoui; Michel Lejoyeux; Pierre A Geoffroy
Journal:  Biol Psychiatry       Date:  2020-06-02       Impact factor: 13.382

3.  A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.

Authors:  Yongsheng Huang; Xiaoyu Lyu; Dan Li; Lin Wang; Yujun Wang; Wenbin Zou; Yingxin Wei; Xiaowei Wu
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

4.  The status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19.

Authors:  Dindial Ramotar
Journal:  Expert Rev Respir Med       Date:  2020-06-30       Impact factor: 3.772

Review 5.  Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.

Authors:  Bogna Grygiel-Górniak
Journal:  Clin Rheumatol       Date:  2021-07-03       Impact factor: 3.650

6.  Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.

Authors:  Tyler Enos; Haneol S Jeong; Travis Vandergriff; Heidi T Jacobe; Benjamin F Chong
Journal:  Dermatol Ther       Date:  2020-07-08       Impact factor: 3.858

Review 7.  COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.

Authors:  Masataka Nishiga; Dao Wen Wang; Yaling Han; David B Lewis; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2020-07-20       Impact factor: 32.419

8.  "Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis."

Authors:  Awadhesh Kumar Singh; Akriti Singh; Ritu Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-05-12

9.  Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.

Authors:  Cong Ye; Shaozhe Cai; Guifen Shen; Hanxiong Guan; Liling Zhou; Yangyang Hu; Wei Tu; Yu Chen; Yikai Yu; Xuefen Wu; Yuxue Chen; Jixin Zhong; Lingli Dong
Journal:  Ann Rheum Dis       Date:  2020-05-22       Impact factor: 27.973

10.  Hydroxychloroquine and QT prolongation: reassuring data in approved indications.

Authors:  Anil Pareek; Tarun S Sharma; Ravi Tejraj Mehta
Journal:  Rheumatol Adv Pract       Date:  2020-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.